Vanguard Total Bond Market Index Fund (BND) vs Johnson & Johnson (JNJ)

Vanguard Total Bond Market ETF is an exchange-traded fund focused on the broad U.S. investment-grade bond market. It provides access to a diversified portfolio of fixed-income securities and is commonly used for income generation, liquidity management, or duration positioning. Its performance is influenced by interest-rate changes, credit spreads, issuer quality, maturity profile, reinvestment yields, and fund expenses. Bond ETFs can still fluctuate in value, especially when rates or credit conditions move quickly.

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.